These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


853 related items for PubMed ID: 8614416

  • 21. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

  • 22. Retinoblastoma protein-overexpressing HL60 cells resistant to 1,25-dihydroxyvitamin D3 display increased CDK2 and CDK6 activity and shortened G1 phase.
    Wang QM, Luo X, Kheir A, Coffman FD, Studzinski GP.
    Oncogene; 1998 May 28; 16(21):2729-37. PubMed ID: 9652739
    [Abstract] [Full Text] [Related]

  • 23. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
    Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM.
    Proc Natl Acad Sci U S A; 2000 Aug 01; 97(16):9042-6. PubMed ID: 10908655
    [Abstract] [Full Text] [Related]

  • 24. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J.
    Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms of cyclin-dependent kinase inactivation by progestins.
    Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL.
    Mol Cell Biol; 1998 Apr 03; 18(4):1812-25. PubMed ID: 9528753
    [Abstract] [Full Text] [Related]

  • 26. NGF regulates the PC12 cell cycle machinery through specific inhibition of the Cdk kinases and induction of cyclin D1.
    Yan GZ, Ziff EB.
    J Neurosci; 1995 Sep 03; 15(9):6200-12. PubMed ID: 7666202
    [Abstract] [Full Text] [Related]

  • 27. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y.
    Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993
    [Abstract] [Full Text] [Related]

  • 28. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.
    J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049
    [Abstract] [Full Text] [Related]

  • 29. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R.
    Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049
    [Abstract] [Full Text] [Related]

  • 30. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells.
    Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T.
    J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912
    [Abstract] [Full Text] [Related]

  • 31. K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
    Nakayama T, Hashimoto Y, Kaneko Y, Kurokawa K.
    Biochem Biophys Res Commun; 1996 Jul 05; 224(1):180-3. PubMed ID: 8694809
    [Abstract] [Full Text] [Related]

  • 32. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM, Lallemand F, Balkenende A, Verwoerd D, Michalides R.
    Oncogene; 2002 Nov 21; 21(53):8158-65. PubMed ID: 12444551
    [Abstract] [Full Text] [Related]

  • 33. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T, Yang JL, Price JO, Arteaga CL.
    Exp Cell Res; 1998 Dec 15; 245(2):350-9. PubMed ID: 9851876
    [Abstract] [Full Text] [Related]

  • 34. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 35. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S, Lowe M, Herliczek TW, Keyomarsi K.
    Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471
    [Abstract] [Full Text] [Related]

  • 36. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 37. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution.
    Planas-Silva MD, Weinberg RA.
    Mol Cell Biol; 1997 Jul 25; 17(7):4059-69. PubMed ID: 9199341
    [Abstract] [Full Text] [Related]

  • 38. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW, Nambirajan S, Moffat JG.
    Oncogene; 1999 Dec 09; 18(52):7477-94. PubMed ID: 10602507
    [Abstract] [Full Text] [Related]

  • 39. Inducible overexpression of cyclin D1 in breast cancer cells reverses the growth-inhibitory effects of antiestrogens.
    Wilcken NR, Prall OW, Musgrove EA, Sutherland RL.
    Clin Cancer Res; 1997 Jun 09; 3(6):849-54. PubMed ID: 9815758
    [Abstract] [Full Text] [Related]

  • 40. Down-regulation of cyclin D1 by transcriptional repression in MCF-7 human breast carcinoma cells induced by flavopiridol.
    Carlson B, Lahusen T, Singh S, Loaiza-Perez A, Worland PJ, Pestell R, Albanese C, Sausville EA, Senderowicz AM.
    Cancer Res; 1999 Sep 15; 59(18):4634-41. PubMed ID: 10493518
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 43.